Chief Financial Officer & Chief Business Officer
Arvind Kush has over 15 years of finance and investment banking experience. Prior to Candid, Arvind was chief financial officer at RayzeBio, where he helped the company raise over $160 million in a private financing in 2022, $350 million+ IPO in 2023 and $4.1 acquisition by BMS in February 2024. Before joining RayzeBio, Arvind was a managing director on the healthcare investment banking team at Bank of America Securities, advising biopharmaceutical companies on strategic and financing transactions. During his 13 years at Bank of America Securities, he executed over $100 billion in M&A transactions and over $12 billion in equity and equity-linked financings. Prior to joining Bank of America Securities, he was an engineer at Caritor India. Arvind holds a Bachelor in Engineering in Computer Science from Visvesvaraya Technological University and an MBA from Goizueta Business School, Emory University.